About University of Chicago Medical Center - Multiple Myeloma Research Consortium
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at University of Chicago Medical Center - Multiple Myeloma Research Consortium
During the past decade, University of Chicago Medical Center - Multiple Myeloma Research Consortium conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Chicago Medical Center - Multiple Myeloma Research Consortium
According to Clinical.Site data, the most researched conditions in "University of Chicago Medical Center - Multiple Myeloma Research Consortium" are
"Refractory Multiple Myeloma" (1 trials), "Relapsed Multiple Myeloma" (1 trials) and "Relapsed/Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "University of Chicago Medical Center - Multiple Myeloma Research Consortium" in a lesser frequency.
Clinical Trials Intervention Types at University of Chicago Medical Center - Multiple Myeloma Research Consortium
Most popular intervention types in "University of Chicago Medical Center - Multiple Myeloma Research Consortium" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (2 trials), "AMG 701" (1 trials), "Carfilzomib" (1 trials), "Daratumumab" (1 trials) and "Pomalidomide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Chicago Medical Center - Multiple Myeloma Research Consortium
The vast majority of trials in "University of Chicago Medical Center - Multiple Myeloma Research Consortium" are
2 trials for "All" genders.
Clinical Trials Status at University of Chicago Medical Center - Multiple Myeloma Research Consortium
Currently, there are NaN active trials in "University of Chicago Medical Center - Multiple Myeloma Research Consortium".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in University of Chicago Medical Center - Multiple Myeloma Research Consortium,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of Chicago Medical Center - Multiple Myeloma Research Consortium, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".